Our obsession with optimization has reached the fertility clinic, and some tech boosters want to push it much further — toward a full “Gattaca stack” for engineering the ideal baby. As Vox’s Jonquilyn Hill reports, in a conversation with journalist Kristen V. Brown, author of the forthcoming book The Immortal Womb, the pitch is alluring, but the science lags well behind the marketing.
Today’s frontier is PGT-P, or preimplantation genetic testing for polygenic risk. Standard IVF screening flags conditions like Down syndrome; PGT-P tries to estimate an embryo’s odds of complex diseases such as heart disease and diabetes. “People will do anything they can to have the healthiest baby possible,” Brown said.
The catch: unlike single-gene disorders such as Huntington’s disease, those conditions are shaped by hundreds of genes, plus environment and lifestyle. That hasn’t stopped some companies from advertising predictions for height, eye color, longevity and even IQ. Only a small number of people use the tests so far, and Brown stresses that “most mainstream medical societies are against this.”
Embryo editing remains illegal in the U.S. and most other countries, though interest is growing — mostly to help couples carrying harmful variants who struggle to get healthy embryos.
Related on the SLP
Then there’s the “Gattaca stack,” a term coined by tech executive Brian Armstrong. The vision: use in vitro gametogenesis to turn skin cells into eggs and sperm, generate huge numbers of embryos, screen them with PGT-P for the “best” ones, and grow them in artificial wombs.
To critics, that sounds a lot like eugenics — a charge parents of children with Down syndrome have long leveled at prenatal screening. Brown also notes the genome simply doesn’t work like a menu. “You can’t actually just go in there and be like, ‘I want a tall baby with blue eyes and a great laugh,'” she said. With so many variables in reproduction, “we are never going to be able to fully control the process.”


















